Related Experiment Video

Updated: Jun 17, 2026

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
05:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Mental illness in parents of phenylketonuric children

M D Blumenthal1

  • 1Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48104, USA.

Journal of Psychiatric Research
|December 26, 2009
PubMed

Insights

Parents of children with phenylketonuria (PKU) showed no increased vulnerability to mental health issues compared to control groups. This study investigated PKU carrier mental health, finding no significant differences in mental disorder susceptibility.

Area of Science:

  • Psychiatry
  • Genetics
  • Public Health

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder.
  • The hypothesis that individuals heterozygous for PKU may be more susceptible to mental disorders requires investigation.
  • Understanding genetic carrier mental health is crucial for comprehensive care.

Purpose of the Study:

  • To investigate the mental health status of individuals presumed to be heterozygous for phenylketonuria (PKU).
  • To compare the mental health of parents of children with PKU to control groups.
  • To determine if PKU carriers exhibit increased vulnerability to mental disorder.

Main Methods:

  • A field study involving 331 participants, including parents of children with PKU, parents of children with non-PKU intellectual disability, and parents of children with cystic fibrosis.
  • Standardized interviews collected data on mental health problems in participants and their relatives.
  • Mental health was assessed using operationalized indices derived from coded interview data.

Main Results:

  • No significant differences in mental health scores were found between parents of children with PKU and the control groups.
  • Social class and sex were associated with variations in mental health indices, aligning with expected patterns.
  • The study's operational definitions of mental illness did not indicate increased susceptibility in PKU carriers.

Conclusions:

  • The findings do not support the hypothesis that individuals heterozygous for PKU are more vulnerable to mental disorder.
  • The study highlights the importance of carefully defined operational measures in psychiatric field research.
  • Further research may be needed to explore subtle or different manifestations of mental health in PKU carriers.

More Related Videos

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...